Aurobindo Pharma Limited (BOM:524804)
1,035.25
+0.20 (0.02%)
At close: Sep 4, 2025
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 601.71 billion as of September 4, 2025. Its market cap has decreased by -31.66% in one year.
Market Cap
601.71B
Enterprise Value
601.92B
Revenue
320.25B
Ranking
n/a
PE Ratio
17.74
Stock Price
1,035.25
Market Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 601.71B, an increase of 6,165.68%. That is a compound annual growth rate of 19.53%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 3, 2025 | 601.07B | -22.45% |
Dec 31, 2024 | 775.08B | 22.03% |
Dec 29, 2023 | 635.16B | 147.32% |
Dec 30, 2022 | 256.82B | -40.31% |
Dec 31, 2021 | 430.28B | -20.29% |
Dec 31, 2020 | 539.83B | 101.66% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Reliance Industries | 18.49T |
HDFC Bank | 14.60T |
Bharti Airtel | 11.39T |
Tata Consultancy Services | 11.26T |
ICICI Bank | 10.08T |
State Bank of India | 7,440.34B |
Hindustan Unilever | 6,289.86B |
Infosys | 6,215.42B |